Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liomont S A De C VfiledCriticalLaboratorios Liomont S A De C V
Priority to MX2015014707ApriorityCriticalpatent/MX2015014707A/en
Publication of MX2015014707ApublicationCriticalpatent/MX2015014707A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
The present disclosure is related to a pharmaceutical composition to be administered parenterally and be used for the treatment of problems related to gastric disorders; using a specific pH adjustment in a range of 10.0 - 12.0, being sodium esomeprazole the specific active ingredient in a lyophilisate to be reconstituted, in which a bulking and/or an antioxidant agent may be used.
MX2015014707A2015-10-202015-10-20Pharmaceutical composition and process for obtaining injectable esomeprazole.
MX2015014707A
(en)
N2, N4-DIPHENYLPYRIMIDINE-2,4-DIAMINE DERIVATIVE, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING IT AS AN ACTIVE INGREDIENT, FOR PREVENTION OF TREATMENT AND TREATMENT